v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 41,384,287 $ 66,046,789
Restricted cash 58,400 58,400
Accounts receivable, net 5,474,956 4,236,136
Inventory 6,394,817 5,123,496
Prepaid expenses and other current assets 4,614,222 3,545,451
Total current assets 57,926,682 79,010,272
Equipment, net 374,692 328,540
Intangible assets, net 6,218,509 391,423
Total assets 64,519,883 79,730,235
Current liabilities    
Accounts payable and accrued liabilities 6,237,986 8,976,904
Current deferred income 103,192 153,171
Other current liabilities 71,540
Total current liabilities 6,412,718 9,130,075
Deferred income 30,170 35,944
Option liability 3,174,662
Warrant liabilities 5,080,530 4,812,198
Other long-term liabilities 34,716 47,181
Total liabilities 11,558,134 17,200,060
Stockholders’ equity    
Common stock, no par value, unlimited shares authorized, 21,774,104 and 21,742,104 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively 133,952,684 133,891,673
Class B preferred stock, no par value, unlimited shares authorized, 316,655 shares issued and outstanding as of June 30, 2026, and December 31, 2025, respectively 62 62
Additional paid-in capital 31,487,837 25,849,516
Accumulated other comprehensive loss (104,301) (104,301)
Accumulated deficit (112,374,533) (97,106,775)
Total stockholders’ equity 52,961,749 62,530,175
Total liabilities and stockholders’ equity $ 64,519,883 $ 79,730,235